000 | 01031 a2200313 4500 | ||
---|---|---|---|
005 | 20250516140800.0 | ||
264 | 0 | _c20130910 | |
008 | 201309s 0 0 eng d | ||
022 | _a1600-5449 | ||
024 | 7 |
_a10.1111/ane.12098 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSatlin, A | |
245 | 0 | 0 |
_aDevelopment of perampanel in epilepsy. _h[electronic resource] |
260 |
_bActa neurologica Scandinavica. Supplementum _c2013 |
||
300 |
_a3-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnticonvulsants _xtherapeutic use |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 | _aDrug Evaluation, Preclinical |
650 | 0 | 4 |
_aEpilepsy _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aNitriles |
650 | 0 | 4 |
_aPyridones _xtherapeutic use |
700 | 1 | _aKramer, L D | |
700 | 1 | _aLaurenza, A | |
773 | 0 |
_tActa neurologica Scandinavica. Supplementum _gno. 197 _gp. 3-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/ane.12098 _zAvailable from publisher's website |
999 |
_c22571916 _d22571916 |